Recent Publications

Articles

• Behavioral tests that reveal long-term deficits after permanent focal cerebral ischemia in mouse.
  Fréchou M, Margaill I, Marchand-Leroux C, Beray-Berthat V : Behav Brain Res, 2019
• Improved Reperfusion and Vasculoprotection by the Poly(ADP-Ribose)Polymerase Inhibitor PJ34 After Stroke and Thrombolysis in Mice.
  El Amki M, Lerouet D, Garraud M, Teng F, Beray-Berthat V, Coqueran B, Barsacq B, Abbou C, Palmier B, Marchand-Leroux C, Margaill I : Mol Neurobiol, 2018
• Recombinant tissue plasminogen activator enhances microparticle release from mouse brain-derived endothelial cells through plasmin.
  Garraud M, Khacef K, Vion AC, Leconte C, Yin M, Renard JM, Marchand-Leroux C, Boulanger CM, Margaill I, Beray-Berthat V : J Neurol Sci, 2016
• Combined therapy with PJ34, a poly(ADP-ribose)polymerase inhibitor, reduces tissue plasminogen activator-induced hemorrhagic transformations in cerebral ischemia in mice.
  Haddad M, Beray-Berthat V, Coqueran B, Plotkine M, Marchand-Leroux C, Margaill I : Fundam Clin Pharmacol, 2013
• Detection of vascular cell adhesion molecule-1 expression with USPIO-enhanced molecular MRI in a mouse model of cerebral ischemia.
  Fréchou M, Beray-Berthat V, Raynaud JS, Mériaux S, Gombert F, Lancelot E, Plotkine M, Marchand-Leroux C, Ballet S, Robert P, Louin G, Margaill I : Contrast Media Mol Imaging, 2013
• Prevention of rt-PA induced blood-brain barrier component degradation by the poly(ADP-ribose)polymerase inhibitor PJ34 after ischemic stroke in mice.
  Teng F, Beray-Berthat V, Coqueran B, Lesbats C, Kuntz M, Palmier B, Garraud M, Bedfert C, Slane N, Bérézowski V, Szeremeta F, Hachani J, Scherman D, Plotkine M, Doan BT, Marchand-Leroux C, Margaill I : Exp Neurol, 2013